GUEST
LIVE

Serial Number

97224127

Owner

GCIP Holdings, LLC

Attorney

Norm J. Rich

Filing Date

Jan 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

GUEST Trademark

Serial Number: 97224127

GUEST is a trademark filed by GCIP Holdings, LLC on January 18, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 34 (Smokers Articles). The application is currently pending registration.

Owner Contact Info

GCIP Holdings, LLC

2209 Nevada Rd
Lakeland, FL 33803

Entity Type: 16

Trademark Details

Filing Date

January 18, 2022

Registration Date

Not Registered

Published for Opposition

August 8, 2023

Goods & Services

Electronic cigarettes, cartridges for use in electronic cigarettes in the nature of electronic cigarette refill cartridges sold empty, and electronic cigarette liquid (e-liquid) comprised of flavorings in liquid form, other than essential oils, used to refill electronic cigarette cartridges

Clothing items, namely, shirts, sweatshirts, hats, beanies, socks, pants, and jackets

Fruit-based beverages

Coffee and tea based beverages; hard candy, baked goods in the nature of bakery desserts, chocolate, sugar-based confectionery, candy, marshmallow, pastry, gum-based confections being gum sweets, gummy candies, candies

Topical medical preparations, medicinal oils, herbal tinctures for medicinal purposes, and powdered nutritional supplement concentrates, all the aforementioned for medical and therapeutic use to treat cancer, epilepsy, glaucoma, HIV, AIDS, seizures, Crohn's disease, chronic muscle spasms, post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis, ADHD, anemia, anxiety, severe arthritis, Alzheimer's Disease, anorexia, autism with self-injurious behavior or aggressive tendencies, Arnold-Chiari malformation, cerebral palsy (CP), chemotherapy side effects, chronic kidney disease, chronic pain of any kind, cystic fibrosis, complex regional pain syndrome, cachexia being wasting syndrome, degenerative disc disorder, decompensated cirrhosis, depression, dystonia, diabetes, electrolyte disturbances, kinetic essential tremor, fibromyalgia, herniated disc, hypoparathyroidism, hepatitis C, hydrocephalus, inflammatory bowel disease, insomnia, irritable bowel syndrome, liver disease, lupus, Lyme disease, muscle spasms, mitochondrial disease, muscular dystrophy, myositis, myasthenia gravis, migraines, neuropathy, nausea, severe nausea, osteoarthritis, osteoporosis, polymyalgia rheumatics, post-polio syndrome, Parkinson's disease, peripheral vascular disease, premenstrual syndrome (PMS), psychiatric conditions, severe psoriasis, post laminectomy syndrome being failed back syndrome, radiation therapy side effects, reflex sympathetic dystrophy, restless legs syndrome, rheumatoid arthritis, scoliosis, spasticity, spinal cord injury, spinal stenosis, sickle cell disease, tardive dyskinesia, temporomandibular joint dysfunction (TMJ) syndrome, Tourette's syndrome, mental, emotional, and blunt force trauma, and ulcerative colitis

Dairy-based food beverages

Filing History

SOU TEAS EXTENSION RECEIVED
Mar 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2025 EXRA
SOU EXTENSION 4 GRANTED
Sep 22, 2025 EX4G
SOU EXTENSION 4 FILED
Sep 22, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 22, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 10, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 10, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 10, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 25, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 25, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 2, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 2, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2022 NWOS
NEW APPLICATION ENTERED
Jan 21, 2022 NWAP